SCHEMBL9535989

SCHEMBL9535989

CC(=O)COc1ccccc1.c1ccc([PH2](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MTNR1A P48039 4/20 0.45
▸ MTNR1B P49286 4/20 0.45
▸ ALPL P05186 1/20 0.45
▸ ALPI P09923 1/20 0.45
▸ ALPG P10696 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746 0.89 ALOX15 (0.68) ALOX15SMN1; SMN2KMT2AMEN1NPC1
Anisole SCHEMBL28851690 0.81 ALOX15 (0.59) ALOX15SMN1; SMN2KMT2AMEN1NPC1
SCHEMBL8225239 0.81 SMN1; SMN2 (0.67) ALOX15SMN1; SMN2RAB9AALDH1A1HTT
SCHEMBL9535986 0.79 ALOX15 (0.55) ALOX15SMN1; SMN2KMT2AMEN1NPC1
SCHEMBL2955123 0.78 HPGD (0.50) ALOX15SMN1; SMN2RAB9AMAPTALDH1A1
SCHEMBL7733929 0.78 MAPT (0.66) ALOX15SMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL20425306 0.75 MAOB (0.70) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL12345884 0.75 ALOX15 (0.50) ALOX15SMN1; SMN2KMT2AMEN1NPC1
SCHEMBL2446915 0.75 ELANE (0.62) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL11528650 0.75 LMNA (0.59) ALOX15L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0241043-B1 NOVEL DIARYLALKANOIDS HAVING ACTIVITY AS LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1993-09-01 — — EP disclosed
US-5177259-A Diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1993-01-05 — — US disclosed
US-5142095-A Treating inflammation, allergies, asthma, cardiovascular disorders, psoriasis WARNER-LAMBERT COMPANY (US) 1992-08-25 — — US disclosed
US-5077411-A Antiallergens, antiinflammatory agents; cardiovascular disorders, migraines, psoriasis WARNER-LAMBERT CO. (US) 1991-12-31 — — US disclosed
US-4959503-A Diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1990-09-25 — — US disclosed
US-4810716-A ANTIINFLAMMATORY, ANTIALLERGY, ANTIISCHEMIC WARNER-LAMBERT COMPANY (US) 1989-03-07 — — US disclosed
EP-0241043-A2 Novel diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1987-10-14 — — EP disclosed
Send feedback